1.Xia Suntong and Physician Catalogue in Cataloged Abstract of Supplement to Si Ku Quan Shu
Journal of Beijing University of Traditional Chinese Medicine 2018;41(4):284-288
As the major contributing editor of Physician Catalogue in Cataloged Abstract of Supplement to Si Ku Quan Shu(Yijia Lei,Xuxiu Siku Quanshu Zongmu Tiyao),Xia Suntong(1857-1942) has been rarely mentioned before in academic community. This paper has documented Xia's qualification, academic association and working attitude through multi-dimension and multi-angle textual analysis. Abundant compiling experience Xia has accumulated as well as his own profound knowledge in bibliography and medicine, have brought great academic value and significant profound impact on his works.
2.Expression of IL-33 in patients with systemic sclerosis and its correlation with TGF-β
Bintao SU ; Lan ZHAO ; Xingfei WU ; Xin CHEN ; Zunyi CHEN ; Botao YIN
Chinese Journal of Clinical Laboratory Science 2018;36(4):267-269
Objective To investigate the expressions of interleukin-33 (IL-33),soluble growth stimulation expressed gene 2 (sST2) and transforming growth factor β1 (TGF-β1) in the patients with systemic sclerosis (SSc) and their correlations.Methods Serum IL-33,sST2 and TGF-β1 levels from 25 SSc patients and 25 healthy controls were determined by an enzyme linked immunosorbent assay (ELISA).The expressions of IL-33 in the damaged skin tissue of SSc patients and normal skin tissue were detected with the immunohistochemical staining.Results Serum IL-33 and TGF-β1 levels in SSc patients were significantly higher than that in healthy controls (P < 0.05),and serum IL-33 levels were positively correlated with TGF-β1 levels in SSc patients (P < 0.05).Immunohistochemical staining results showed that the expression level of IL-33 in the damaged skin tissue of SSc patients were significantly higher than that in normal skin tissue (P < 0.05).However,there was no significant difference in the expression level of sST2 between SSc patinets and healthy controls.Conclusion Serum IL-33 levels in SSc patients increase significantly,which is correlated with the expression of TGF-β1,indicating that IL-33 may play an important role in the process of inflammation and fibrosis of SSc via the regulation of TGF-β1.